Company / Shares Outstanding
Rapport Therapeutics, Inc. Shares Outstanding History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
20.7M
FY2024
5-year range
1.5M / 20.7M
FY2023-FY2024
Trend
+1277.3%
vs FY2023
Sector context
#199 of 212
Health Care
What the data says
Among 212 Health Care companies, Rapport Therapeutics, Inc. is in the top 6% for shares outstanding.
Based on SEC 10-K filings.
20738338.00 in FY2024.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 212This company 20.7M Sector average 306.7M
▼
-93.2% below sector average
Key checks
Key Insights
- In FY2024, shares outstanding increased 1277.3% year-over-year.
- Ranks #199 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 13.36 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 20.7M | +1277.3% |
| FY2023 | 1.5M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026